Inivata Inc., a pioneering force in the biotechnology sector, is headquartered in the United States and operates across key regions globally. Founded in 2014, the company has made significant strides in the field of cancer diagnostics, particularly through its innovative liquid biopsy technology. Inivata's flagship product, InVisionFirst®, offers a non-invasive solution for detecting and monitoring cancer, setting it apart with its ability to provide comprehensive genomic insights from a simple blood sample. With a strong emphasis on precision medicine, Inivata has positioned itself as a leader in the oncology diagnostics market, achieving notable milestones such as strategic partnerships and advancements in clinical research. The company's commitment to improving patient outcomes through advanced diagnostic solutions underscores its reputation as a trusted name in the industry.
How does Inivata Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Inivata Inc.'s score of 29 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Inivata Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of NeoGenomics Laboratories, Inc., which may influence its climate commitments and reporting practices. As a subsidiary, Inivata's climate initiatives and targets may be aligned with those of its parent company, NeoGenomics, which operates at a cascade level of 2. However, specific reduction targets or achievements for Inivata are not detailed in the available information. Inivata has not publicly committed to any specific climate pledges or reduction initiatives, nor does it have any Science-Based Targets Initiative (SBTi) targets reported. This lack of data suggests that Inivata may still be in the early stages of developing its carbon reduction strategy or may rely on the broader corporate strategies of its parent company. Overall, while Inivata Inc. does not currently provide emissions data or specific climate commitments, its relationship with NeoGenomics Laboratories may play a role in shaping its future sustainability efforts.
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | |
|---|---|
| Scope 1 | 536,000 |
| Scope 2 | 4,181,000 |
| Scope 3 | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Inivata Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.